Phase 2 and 3 Validation of Protein Biomarkers for the Early Detection of Breast Cancer Discovered Using a Mass Spectrometry-Based Platform
- Abbreviated Name
- Phase 2 and 3 Validation of Protein Biomarkers for the Early Detection of Breast Cancer Discovered Using a Mas
- Lead Investigator
- Hanash, Samir — The University of Texas MD Anderson Cancer Center
- Coordinating Investigator
- Hanash, Samir — The University of Texas MD Anderson Cancer Center
- Involved Investigators
Abstract
No abstract availalbe.
Aims
No aims available.
Analytic Method
No analytic method available.
Comments
No comments available.
Outcome
No outcome available.
Secure Outcome
No secure outcome available.
Publications
- No publications available at this time for this protocol.
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
- Start Date
- Sep 1 2023
- Protocol ID
- 529
- Protocol Type
- Single
- Fields of Research
-
- UNKNOWN
- Collaborative Group
- Breast and Gynecologic Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of breast